Literature DB >> 30859496

Various associations of aging and long-term HIV infection with different neurocognitive functions: detailed analysis of a Japanese nationwide multicenter study.

Kensuke Komatsu1, Ei Kinai2, Maiko Sakamoto3, Toshibumi Taniguchi4, Aya Nakao5, Tatsuro Sakata6, Akiko Iizuka6, Teppei Koyama7, Toki Ogata8, Akihiro Inui9, Shinichi Oka1.   

Abstract

Detailed information of the effects of age and long-term HIV infection on various neurocognitive function have not been fully evaluated yet. In a prospective Japanese nationwide multicenter study of 17 facilities (J-HAND study), 728 HIV-infected individuals completed 14 neuropsychological (NP) tests; Verbal Fluency (VF; category and letter), Digit Span (DS; forward and backward), Trail Making Test (TMT) A-B, Rey-Osterrieth Complex Figure Test (ROCFT; copy, immediate and delayed recall), Story Memory Test (SMT; immediate and delayed recall), Digit Symbol Subset (DSS), and the Grooved Pegboard (GP; dominant and non-dominant). Multivariate analysis identified older age (≥ 50 years) to be associated with lower scores in all three ROCFT and GP dominant [odds ratio (OR) [95% confidence interval (CI)] 1.801 (1.217-2.664), 2402 (1.366-3.055), 2.691 (1.720-4.211), and 2.302 (1.145-4.628), respectively], whereas longer time since diagnosis was associated with a lower score in ROCFT (delayed recall) (OR 1.224, 95%CI 1.045-1.434). In VF letter, older age and longer time since diagnosis were associated with a better score [OR (95%CI) 0.449 (0.234-0.861) and 0.831 (0.692-0.997)]. In DSS and TMT-A, longer time since diagnosis was associated with a better score [OR (95%CI): 0.808 (0.670-0.973) and 0.795 (0.665-0.949), respectively]. Older patients in later years since diagnosis are at higher risk of visuospatial and motor impairments despite ART, whereas they are less likely to develop verbal impairment, suggesting that verbal function is relatively resistant to aging and long history of HIV infection under ART. These findings suggest that customtailored supports should be established based on the individual background.

Entities:  

Keywords:  Aging; HIV-associated neurocognitive disorder; Motor function; Verbal function; Visuospatial function

Mesh:

Substances:

Year:  2019        PMID: 30859496     DOI: 10.1007/s13365-018-0704-7

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  29 in total

1.  [Normative data on tests for frontal lobe functions: Trail Making Test, Verbal fluency, Wisconsin Card Sorting Test (Keio version)].

Authors:  Mitsuyo Abe; Kyoko Suzuki; Kazue Okada; Rina Miura; Toshikatsu Fujii; Mori Etsurou; Atsushi Yamadori
Journal:  No To Shinkei       Date:  2004-07

2.  Dynamics of cognitive change in HIV-infected individuals commencing three different initial antiretroviral regimens: a randomized, controlled study.

Authors:  A Winston; R Puls; S J Kerr; C Duncombe; P C K Li; J M Gill; S D Taylor-Robinson; S Emery; D A Cooper
Journal:  HIV Med       Date:  2011-12-12       Impact factor: 3.180

3.  Reliability and validity of Japanese version of the Mini-International Neuropsychiatric Interview.

Authors:  Tempei Otsubo; Katsutoshi Tanaka; Rumiko Koda; Junko Shinoda; Nana Sano; Satoshi Tanaka; Hiroshi Aoyama; Masaru Mimura; Kunitoshi Kamijima
Journal:  Psychiatry Clin Neurosci       Date:  2005-10       Impact factor: 5.188

4.  A multimodal assessment of driving performance in HIV infection.

Authors:  T D Marcotte; T Wolfson; T J Rosenthal; R K Heaton; R Gonzalez; R J Ellis; I Grant
Journal:  Neurology       Date:  2004-10-26       Impact factor: 9.910

5.  Updated research nosology for HIV-associated neurocognitive disorders.

Authors:  A Antinori; G Arendt; J T Becker; B J Brew; D A Byrd; M Cherner; D B Clifford; P Cinque; L G Epstein; K Goodkin; M Gisslen; I Grant; R K Heaton; J Joseph; K Marder; C M Marra; J C McArthur; M Nunn; R W Price; L Pulliam; K R Robertson; N Sacktor; V Valcour; V E Wojna
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

6.  Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort.

Authors:  Jessica Robinson-Papp; Desiree Byrd; Monica Rivera Mindt; Neal Leonard Oden; David M Simpson; Susan Morgello
Journal:  Arch Neurol       Date:  2008-08

7.  Effect of age and education on the Trail Making Test and determination of normative data for Japanese elderly people: the Tajiri Project.

Authors:  Ryusaku Hashimoto; Kenichi Meguro; Eunjoo Lee; Mari Kasai; Hiroshi Ishii; Satoshi Yamaguchi
Journal:  Psychiatry Clin Neurosci       Date:  2006-08       Impact factor: 5.188

8.  HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.

Authors:  R K Heaton; D B Clifford; D R Franklin; S P Woods; C Ake; F Vaida; R J Ellis; S L Letendre; T D Marcotte; J H Atkinson; M Rivera-Mindt; O R Vigil; M J Taylor; A C Collier; C M Marra; B B Gelman; J C McArthur; S Morgello; D M Simpson; J A McCutchan; I Abramson; A Gamst; C Fennema-Notestine; T L Jernigan; J Wong; I Grant
Journal:  Neurology       Date:  2010-12-07       Impact factor: 9.910

9.  Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors.

Authors:  Valerio Tozzi; Pietro Balestra; Rita Bellagamba; Angela Corpolongo; Maria Flora Salvatori; Ubaldo Visco-Comandini; Chrysoula Vlassi; Marinella Giulianelli; Simonetta Galgani; Andrea Antinori; Pasquale Narciso
Journal:  J Acquir Immune Defic Syndr       Date:  2007-06-01       Impact factor: 3.731

10.  HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors.

Authors:  Robert K Heaton; Donald R Franklin; Ronald J Ellis; J Allen McCutchan; Scott L Letendre; Shannon Leblanc; Stephanie H Corkran; Nichole A Duarte; David B Clifford; Steven P Woods; Ann C Collier; Christina M Marra; Susan Morgello; Monica Rivera Mindt; Michael J Taylor; Thomas D Marcotte; J Hampton Atkinson; Tanya Wolfson; Benjamin B Gelman; Justin C McArthur; David M Simpson; Ian Abramson; Anthony Gamst; Christine Fennema-Notestine; Terry L Jernigan; Joseph Wong; Igor Grant
Journal:  J Neurovirol       Date:  2010-12-21       Impact factor: 2.643

View more
  2 in total

Review 1.  Pathogenesis, clinical course, and recent issues in HIV-1-infected Japanese hemophiliacs: a three-decade follow-up.

Authors:  Shinichi Oka; Kazuko Ikeda; Misao Takano; Miwa Ogane; Junko Tanuma; Kunihisa Tsukada; Hiroyuki Gatanaga
Journal:  Glob Health Med       Date:  2020-02-29

2.  Altered white matter microstructure and neurocognitive function of HIV-infected patients with low nadir CD4.

Authors:  Yujiro Yoshihara; Tadatsugu Kato; Dai Watanabe; Masaji Fukumoto; Keiko Wada; Naoya Oishi; Takahiro Nakakura; Keiko Kuriyama; Takuma Shirasaka; Toshiya Murai
Journal:  J Neurovirol       Date:  2022-07-01       Impact factor: 3.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.